MICROBIOTIC INTESTINAL IMBALANCE IN CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Main Article Content
Abstract
The aim – to evaluate the frequency of small intestinal bacterial overgrowth and the level of systemic endotoxemia in children with non-alcoholic fatty liver disease.
Materials and methods. 98 children with constitutionally exogenous obesity were examined in Donetsk City Children's Clinical Hospital N 1. Group 1 consisted of 60 children with non-alcoholic fatty liver disease. Group 2 included 38 obese children without signs of liver damage. The prevalence of small intestinal bacterial overgrowth and the systemic endotoxemia were determined in all patients. The control group consisted of 30 children with normal body weight.
Results. Small intestinal bacterial overgrowth was detected in 72.4 ± 4.5 % of obese children, which was statistically significant (p < 0,001) more often than in children of the control group – 13.3 ± 6.2 %. In group 1, small intestinal bacterial overgrowth was detected in 55.3 8.1 %, and in group 2 – in 83.3 4.8 % (p < 0.01).
In the control group, 93.3 4.6 % of children had a physiological level of endotoxemia (˂ 1,0 EU/мл), the average value of lipopolysaccharides in the group was 0.6 ± 0.1 EU/ml. Among obese patients, the majority had an increased concentration of lipopolysaccharides in the blood serum – 68.4 ± 4.7 %. In group 2, an increase in lipopolysaccharides in blood serum was found in 36.8 7.8 % of children, and in group 1 – in 88.0 4.2 % (p < 0.001). In group 1, the average value of lipopolysaccharides was 1.7 0.1 EU/ml, in group 2 – 1.0 0.1 EU/ml (p < 0.001).
Conclusions. For patients with constitutionally exogenous obesity, the small intestinal bacterial overgrowth is characteristic. At the same time, in children with non-alcoholic fatty liver disease, microbiotic imbalance in the small intestine is recorded significantly more often than in obese patients without signs of liver damage. The small intestinal bacterial overgrowth in obese children occurs against the background of the development of systemic endotoxemia.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945): 766-781. DOI: 10.1016/S0140-6736(14)60460-8
Pogodina AV, Romanica AI, Rychkova LV. Obesity and functional disorders of the intestine in children. Pediatrician (St. Petersburg). 2021; 12(1): 59-69. Russian (Погодина А.В., Романица А.И., Рычкова Л.В. Ожирение и функциональные расстройства кишечника у детей //Педиатр. 2021. Т. 12, № 1. С. 59-69.) DOI: 10.17816/PED12159-69
Minjajlova NN, Rovda JuI, Chernykh NS. Chronic eating disorders in young children – obesity (paratrophy): pathogenetic mechanisms, risk factors, prevention and correction of overweight nutrition (lecture). Mother and Baby in Kuzbass. 2021; 2(85): 52-63. Russian (Миняйлова Н.Н., Ровда Ю.И., Черных Н.С. Хронические расстройства питания у детей раннего возраста – ожирение (паратрофия): патогенетические механизмы, факторы риска, профилактика и коррекция питания при избыточной массе (лекция) //Мать и Дитя в Кузбассе. 2021. № 2(85). С. 52-63)
Zhdanova NA, Eroshenko KP, Alekseeva AL, Bolgova I.V., Elgina SI, Mozes VG, Rudaeva EV. Obesity in children and adolescents (aspects of diagnosis and treatment in outpatient settings). Mother and Baby in Kuzbass. 2021; №3(86): 95-98. Russian (Жданова Н.А., Ерошенко К.П., Алексеева А.Л., Боkгова И.В., Елгина С.И., Мозес В.Г., Рудаева Е.В. Ожирение у детей и подростков (аспекты диагностики и лечения в амбулаторных условиях) //Мать и Дитя в Кузбассе. 2021. № 3(86). С. 95-98)
Tutel'jan VL, Baturin AK, Kon' IJa, Martinchik AN, Uglickih AK, Korosteleva MM, et al. Prevalence of obesity and overweight among the children's population of the Russian Federation: a multicenter study. Pediatria named after G.N. Speransky. 2014; 93(5): 28-31. Russian (Тутельян В.Л., Батурин А.К., Конь И.Я., Мартинчик А.Н., Углицких А.К., Коростелева М.М., и др. Распространенность ожирения и избыточной массы тела среди детского населения РФ: мультицентровое исследование //Педиатрия им. А.Н. Сперанского. 2014. Т. 93, № 5. С. 28-31)
Loranskaya ID, Stepanova EV, Kupaeva VA. Gut microbiota and obesity. Experimental and Clinical Gastroenterology. 2017; 3: 79-83. Russian (Лоранская И.Д., Степанова Е. В., Купаева В. А. Микрофлора желудочно-кишечного тракта и ожирение //Экспериментальная и клиническая гастроэнтерология. 2017. № 3. 79-83)
Naletov AV, Masjuta DI, Chalaja LF. Pathogenetic basis of irritable bowel syndrome in patients who have undergone COVID-19. Mother and Baby in Kuzbass. 2021; 4(87): 12-16. Russian (Налетов А.В., Масюта Д.И., Чалая Л.Ф. Патогенетические основы синдрома раздраженного кишечника у пациентов, перенесших COVID-19 //Мать и Дитя в Кузбассе. 2021. № 4(87). 12-16)
Naletov AV, Masjuta DI. Syndrome of excessive bacterial growth of the small intestine in children with chronic gastroduodenal pathology associated with H. pylori. Experimental and Clinical Gastroenterology. 2016; 12: 13-16. Russian (Налетов А.В., Масюта Д.И. Синдром избыточного бактериального роста тонкой кишки у детей с хронической гастродуоденальной патологией, ассоциированной с Н. pylori //Экспериментальная и клиническая гастроэнтерология. 2016. № 12. С. 13-16)
Novikova VP, Gurova MM. Gastrointestinal tract and obesity in children. SPb.: SpecLit. 2016. 302 p. Russian (Новикова В.П., Гурова М.М. Желудочно-кишечный тракт и ожирение у детей. СПб.: СпецЛит. 2016. 302 с.)
Jakovlev MJu. Intestinal endotoxin: immunity – inflammation – aging, as links of the same chain. Pathogenesis. 2020; 18(1): 82-94. Russian (Яковлев М.Ю. Кишечный эндотоксин: иммунитет – воспаление – старение, как звенья одной цепи //Патогенез. 2020. Т. 18, № 1. С. 82-94)
Yao Q, Yu Z, Meng Q, Chen J, Liu Y, Song W, et al. The role of small intestinal bacterial overgrowth in obesity and its related diseases. Biochem Pharmacol. 2023; 212: 115546. DOI: 10.1016/j.bcp.2023.115546
Roland BC, Lee D, Miller LS, Vegesna A, Yolken R, Severance E, et al. Obesity increases the risk of small intestinal bacterial overgrowth (SIBO). Neurogastroenterol Motil. 2018; 30(3). DOI: 10.1111/nmo.13199
Esposito S, Biscarini A, Federici B, Cofini M, Argentiero A, Neglia C, et al. Role of small intestinal bacterial overgrowth (sibo) and inflammation in obese children. Front Pediatr. 2020; 8: 369. DOI: 10.3389/fped.2020.00369
Shi H, Mao L, Wang L, Quan X, Xu X, Cheng Y, et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2021; 33(Suppl 1): e535-e539. DOI: 10.1097/MEG.0000000000002157